7 Rheumatoid Arthritis Clinical Trials in Bakersfield, CA (2026)

Q: How do I join a clinical trial in Bakersfield?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you.

Recruiting Rheumatoid Arthritis Studies in Bakersfield

NCT07200830Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

This randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of life without decreasing...

Bakersfield, CAPHASE31,524 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT05407636Recruiting

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AMD is characterized by ...

Bakersfield, CAPHASE3714 participantsAbbVie

View Study Details

NCT06659445Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

The purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment frequencies in patients wi...

Bakersfield, CAPHASE2324 participantsONL Therapeutics

View Study Details

NCT06619860Recruiting

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)...

Bakersfield, CAPHASE2300 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT07482176Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

This is a multi-center, randomized, double-masked, active-comparator-controlled, Phase 3 study in a broad participant population (treatment-naïve and treatment-experienced) with neovascular (wet) age-...

Bakersfield, CAPHASE3284 participantsAdverum Biotechnologies, Inc.

View Study Details

NCT04853251Recruiting

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W)....

Bakersfield, CAPHASE4188 participantsGenentech, Inc.

View Study Details

NCT06774131Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO \[mitomycin\] for pyelocalyceal solution), instilled in t...

Bakersfield, CAPHASE370 participantsUroGen Pharma Ltd.

View Study Details

About Rheumatoid Arthritis Clinical Trials in Bakersfield

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 7 rheumatoid arthritis clinical trials recruiting participants in Bakersfield, CA. These studies are seeking a combined 3,404 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, AbbVie, ONL Therapeutics and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Bakersfield — FAQ

Are there rheumatoid arthritis clinical trials in Bakersfield?

Yes, there are 7 rheumatoid arthritis clinical trials currently recruiting in Bakersfield, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bakersfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you about next steps.

Are clinical trials in Bakersfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bakersfield studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 7 active trials in Bakersfield are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated July 22, 2026 from ClinicalTrials.gov